NSE filing, NSE: EMAPARTNER. Summary written from the filing by ALFA Finder's alert engine.
EMA Partners India Ltd: key numbers
- Share price
- ₹83.35
- Market cap
- ₹193.8 Cr
- Revenue (annual)
- ₹87.36 Cr
- Net profit (annual)
- ₹12.31 Cr
- P/E (TTM)
- 15.8×Sector 43.1×
- Promoter holding
- 65.76%
- FII holding
- 0.12%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from EMA Partners India Ltd
All →EMA Partners India Other Announcement
EMA Partners India Limited filed its Regulation 74(5) certificate for the quarter ended September 30, 2026, confirming no rematerialisation requests were received.
EMA Partners India Partnership
EMA Partners India Limited has entered a strategic partnership with STAIR Digital to launch EMA STAIR Board Services. The collaboration focuses on board governance, strategy, and AI-driven advisory.
EMA Partners India Annual General Meeting
EMA Partners India Limited held its 23rd Annual General Meeting on September 28, 2026, via video conference, discussing financial statements and director appointments.
EMA Partners India Merger & Restructuring
EMA Partners India Limited is merging three of its wholly owned subsidiaries into itself. No consideration is payable for this internal restructuring.
EMA Partners India Acquisition
EMA Partners India Limited announced a fast-track merger of its wholly-owned subsidiaries, EMA Partners Executive Search, Emagine People Technologies, and EMA Decision Dynamics, with itself.
EMA Partners India Other Announcement
EMA Partners sent Reg 36(1)(b) letters to shareholders without registered emails, providing a web-link to the FY26 Annual Report and 23rd AGM notice. No financial figures or business event are disclosed.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date